BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,047 filers reported holding BAXTER INTL INC in Q4 2018. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,985,344 | -18.0% | 105,600 | -1.0% | 0.04% | -15.4% |
| Q2 2023 | $4,861,252 | +5.1% | 106,700 | -6.4% | 0.05% | -3.7% |
| Q1 2023 | $4,623,840 | -29.2% | 114,000 | -11.0% | 0.05% | -27.0% |
| Q4 2022 | $6,529,257 | +3.5% | 128,100 | +9.4% | 0.07% | -3.9% |
| Q3 2022 | $6,307,000 | -17.8% | 117,100 | -1.9% | 0.08% | -23.0% |
| Q2 2022 | $7,669,000 | -25.2% | 119,400 | -9.8% | 0.10% | -14.5% |
| Q1 2022 | $10,259,000 | -3.7% | 132,300 | +6.6% | 0.12% | +9.3% |
| Q4 2021 | $10,653,000 | +7.3% | 124,100 | +0.6% | 0.11% | -4.5% |
| Q3 2021 | $9,925,000 | -48.6% | 123,400 | -47.4% | 0.11% | -8.9% |
| Q2 2021 | $19,308,000 | +100.5% | 234,400 | +105.3% | 0.12% | -8.9% |
| Q1 2021 | $9,632,000 | +18.7% | 114,200 | +13.0% | 0.14% | +10.7% |
| Q4 2020 | $8,112,000 | +16.2% | 101,100 | +16.5% | 0.12% | -15.3% |
| Q3 2020 | $6,980,000 | -39.0% | 86,800 | -34.7% | 0.14% | -52.2% |
| Q2 2020 | $11,443,000 | +145.6% | 132,900 | +131.5% | 0.30% | +80.2% |
| Q1 2020 | $4,660,000 | +21.4% | 57,400 | +30.8% | 0.17% | +4.4% |
| Q3 2019 | $3,840,000 | +6.5% | 43,900 | -0.2% | 0.16% | -1.2% |
| Q2 2019 | $3,604,000 | -12.1% | 44,000 | -12.7% | 0.16% | -10.5% |
| Q1 2019 | $4,098,000 | +19.5% | 50,400 | -3.3% | 0.18% | +11.0% |
| Q4 2018 | $3,429,000 | -25.1% | 52,100 | -12.3% | 0.16% | -11.4% |
| Q3 2018 | $4,579,000 | – | 59,400 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 298,721 | $23,969,000 | 8.70% |
| GENERATION INVESTMENT MANAGEMENT LLP | 17,424,560 | $1,398,147,000 | 6.24% |
| Soditic Asset Management LLP | 77,950 | $6,255,000 | 6.24% |
| Veritas Asset Management LLP | 11,110,132 | $891,477,000 | 5.32% |
| Dash Acquisitions Inc. | 84,560 | $6,785,000 | 4.74% |
| Prosight Management, LP | 121,075 | $9,715,000 | 4.49% |
| TSFG, LLC | 94,977 | $7,621,000 | 4.07% |
| CINCINNATI FINANCIAL CORP | 1,344,648 | $107,895,000 | 2.93% |
| Dundas Partners LLP | 204,535 | $19,304,000 | 2.82% |
| Unified Trust Company, N.A. | 59,491 | $4,689,000 | 2.72% |